Non-Current Assets
Intangibles (Net)
Amgen Intangibles (Net) decreased by 4.2% to $20.67B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.2%, from $24.66B to $20.67B. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows an upward trend with a 5.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
High levels indicate significant investment in intellectual property, though they are subject to impairment risk if drug candidates fail.
Detailed definition
The value of non-physical assets such as patents, trademarks, and licensing agreements, net of accumulated amortization....
Peer comparison
Very high in biotech compared to other sectors due to the reliance on drug patents.
Metric ID:
intangible_assets_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.28B | $14.63B | $15.18B | $13.55B | $12.91B | $12.26B | $16.08B | $14.38B | $13.69B | $12.99B | $32.64B | $30.22B | $29.02B | $27.83B | $27.70B | $24.66B | $23.90B | $22.43B | $21.57B | $20.67B |
| QoQ Change | — | -4.2% | +3.8% | -10.8% | -4.7% | -5.0% | +31.2% | -10.5% | -4.8% | -5.1% | +151.2% | -7.4% | -4.0% | -4.1% | -0.5% | -11.0% | -3.1% | -6.2% | -3.8% | -4.2% |
| YoY Change | — | — | — | — | -15.5% | -16.2% | +5.9% | +6.2% | +6.1% | +6.0% | +103.0% | +110.1% | +112.0% | +114.2% | -15.1% | -18.4% | -17.6% | -19.4% | -22.1% | -16.2% |
Range$12.26B – $32.64B
CAGR+6.6%
Avg YoY Growth+20.2%
Median YoY Growth-4.6%
Current Streak9 quarters decline
Product Breakdown
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is Amgen's intangibles (net)?
- Amgen (AMGN) reported intangibles (net) of $20.67B in Q1 2026.
- How has Amgen's intangibles (net) changed year-over-year?
- Amgen's intangibles (net) decreased by 16.2% year-over-year, from $24.66B to $20.67B.
- What is the long-term trend for Amgen's intangibles (net)?
- Over 5 years (2020 to 2025), Amgen's intangibles (net) has grown at a 5.4% compound annual growth rate (CAGR), from $16.59B to $21.57B.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and licenses owned by the company.